Navigation Links
Rigel to Present at Keystone Symposia Conference
Date:1/23/2009

SOUTH SAN FRANCISCO, Calif., Jan. 23 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will be presenting at the Keystone Symposia conference on Multiple Sclerosis taking place this week in Santa Fe, New Mexico.

Presentation Date: Sunday, January 25, 2009

Time: 2:30 - 4:30pm

Session: Workshop 2: New Therapeutic Approaches to MS

Presentation Title: The orally bioavailable Protein Kinase C Inhibitor RGE-80 can abrogate EAE disease induction and ameliorates disease in a therapeutic setting

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

Contact: Raul Rodriguez

Phone: 650.624.1302

Email: invrel@rigel.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Phase 2 Results of Rigels R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL
2. Rigel to Present at the Piper Jaffray Annual Health Care Conference
3. Rigel to Present at the Oppenheimer 19th Annual Healthcare Conference
4. Rigel to Webcast Investor Update on October 27, 2008
5. QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc.
6. Rigel to Present at Collins Stewart Growth Conference
7. Rigel Announces First Quarter 2008 Financial Results
8. Rigel to Present at 8th Annual Fortis Bank Biotechnology Conference
9. Rigel Announces Participation in Upcoming Investor and Partnering Conferences
10. Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research
11. Rigel Announces Offering of 4,000,000 Shares of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., , NEW YORK, Dec. 4 Tho... than 90 offices nationwide today, to participate ...dit, tax and advisory firm,s support for literacy ...ice day reflects our firm,s long history of volunt...gathered in the spirit of caring to brighten the h...
(Date:12/4/2009)..., , SCOTTSDALE, Ariz., Dec. 4 /PRNewswire/...elf-managed, non-traded, real estate investment tr...e agreement to acquire a three building medical of...cana, Texas, and Fort Wayne, Indiana for approxima...is subject to the satisfaction of a number of cond...
(Date:12/4/2009)..., , WASHINGTON, Dec. 4 /PRNewswire-USNew...re reform would control health care costs, Leapfro...ead through example -- delivering the best quality...vels of efficiency. Thirty-four urban, eight child...09 Leapfrog Top Hospitals, based on results from T...
(Date:12/4/2009)..., Working with mice, scientists at Johns Hopkins...ave shown that a protein made by a gene called "Tw...ately distinguish stem cells that drive aggressive...r cells. , Building on recent work suggesting th...in breast tumors that drives breast cancer, scient...
(Date:12/4/2009)... Dental tourism is a phen...g for an alternative to the high price of dental w...ir search for lower priced dental care, people hav...oice as a dental tourist destination. , ...eing in business for more than 6 years, Mexican De...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
...ew University of Cincinnati (UC) childhood brain a...ying vascular malformations. In a retrosp...l (brain) arterial aneurysms, Todd Abruzzo, MD, fo...al warnings signs or underlying medical causes, su...
... of humour may help their babies fight skin allerg...ay's issue of New Scientist. Japanese resea... Hospital recruited breastfeeding mums who had a b...r breast milk was taken for testing at regular int...
... effectively treats patients with heart disease. ...sistance is rare, less than 5 percent, at all dose...aken by millions of patients to prevent and treat ... blood flow within arteries, resulting in a heart ...
...he workings of the human genome has led scientists...chemical code for life is badly flawed. The groun... papers in journals on both sides of the Atlantic,...national team of investigators, the four-year proj...
...dubbed as being preoccupied with the physical aspe...d women change their gender roles when they are in... of Florida study demonstrates that men are under ...es once both the genders bond in a romantic relati...
...he use of a specific contact lens solution is very... rare severe eye infection. The study, by...ished online by the American Journal of Ophthalmol... look for possible contact lens-related causes for...
Other Medicine News:Health News:Different Causes for Childhood Brain Aneurysm was Revealed 2Health News:Landmark Study Prompts Rethink of Genetic Code 2Health News:Landmark Study Prompts Rethink of Genetic Code 3Health News:Men and Women Change Attitudes to Sex When in an Intimate Relationship 2Health News:Men and Women Change Attitudes to Sex When in an Intimate Relationship 3Health News:Link Between Eye Infections and Contact Lens Use Exposed 2
(Date:12/4/2009)...NGTON, Dec. 4 Chemistr...shed by the Pharmaceutical Research and Manufactu...drugs and vaccines in development for HIV/AIDS and...hat the 97 products in development include 23 vacc...human clinical trials or awaiting approval by the ...
(Date:12/4/2009).... 4 PharmAthene, Inc. (N...medical countermeasures against biological and che... presenting results of a study demonstrating the e...thrax model in the New Zealand White (NZW) rabbit....ion at the HHS Public Health Emergency Medical Cou...
(Date:12/4/2009)...STON, Dec. 4 OrthoAccel Technologi...hich is an acceleration device to enhance orthodon...ng Education course published by PennWell Corpora... industries, including medicine and dentistry. Th...c treatment, a summary of treatment biomechanics, ...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 1State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 2State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 3Korea Institute of Toxicology Implementing Xybion 26apos 3Bs Pristima 26amp 3B 238482 3B 13553 1Korea Institute of Toxicology Implementing Xybion 26apos 3Bs Pristima 26amp 3B 238482 3B 13553 2Patheon Announces Date of Third Quarter 2009 Financial Results Release Conference Call and Webcast 54467 1Patheon Announces Date of Third Quarter 2009 Financial Results Release Conference Call and Webcast 54467 2
...E: LLY ) has submitted a supplemental New Drug Ap...tration (FDA) seeking approval for a new,indicatio...ent of chronic,pain, the company announced today. ...ials in chronic osteoarthritis pain of the knee an...previously completed pain studies in,diabetic peri...
...ccessfully placed in three patient...May 29 Three patients with established,cardiac is... vProtect,Luminal Shield, a self-expanding intraco...y that typically occurs when stents are deployed. ...ort for the vessel to ensure that,the target coron...
Other Medicine Technology:Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration 2Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration 3Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield 2
Avitene Flour
CODMAN Steerable Neuroendoscope
D185 MultiPulse Cortical Stimulator
The Wilson Plus Radiolucent Wilson Frame
Medicine Products: